Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael H Silverman
Can-Fite BioPharma Ltd
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Complex Oncology Center - Plovdiv
Plovdiv, Bulgaria
- Multiprofile Hospital for Active Treatment Central Onco Hospita
Plovdiv, Bulgaria
- Multiprofile Hospital for Active Treatment "tokuda Hospital Sofia" Ad
Sofia, Bulgaria
- Multiprofile Hospital for Active Treatment Serdica
Sofia, Bulgaria
- Multiprofile Hospital for Active Treatment for Women'S Health - Nadezhda
Sofia, Bulgaria
- Multiprofile Hospital for Active Treatment "sveta Marina" Ead
Varna, Bulgaria
- Rabin Medical Center
Petah Tikva, Israel
- Institutul Clinic Fundeni - Sectia Oncologie Medicala
Bucharest, Romania
- Clinica Bendis - Oncologie Medicala
Cluj-Napoca, Romania
- Centrul de Oncologie Oncolab
Craiova, Romania
- Institutul Regional de Oncologie Iasi - Sectia Oncologie Medicala
Iași, Romania
- Spitalul Pelican Impex Srl- Sectia Oncologie Medicala
Oradea, Romania
- Sc Dacmed Srl - Oncologie
Ploieşti, Romania
- Spitalului Clinic Judetean de Urgenta - Sectia Oncologie Medicala
Sibiu, Romania
- Spitalul Judetean de Urgenta "sf. Ioan Cel Nou" - Sectia Oncologie Medicala
Suceava, Romania
- Vojnomedicinska Akademija Beograd
Belgrade, Serbia
- Institut Za Onkologiju Vojvodine
Kamenitz, Serbia
- Zdravstveni Centar Kladovo Služba Onkologije
Kladovo, Serbia
- Klinički Centar Niš Klinika Za Onkologiju
Niš, Serbia
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Simmons Cancer Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2014
- Primary completion
- 27 Nov 2017
- Completion
- 31 Dec 2021
- Last update posted
- 4 Oct 2022
- Registered enrollment
- 78
- Registry id
- NCT02128958
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.